Vaginal atrophy and sexual function of postmenopausal women. Postmenopausal atrophic vaginitis
Conditions
Interventions
Intervention 1: Intervention group: after the preparation of the oxytocin powder, by the trusted pharmacist Ahvaz University of Medical Sciences will be made oxytocin vaginal gel 400 IU and will be gi
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
40 Years to 60 Years
Inclusion criteria
Inclusion criteria: Have reading and writing skills Women aged 40-60 Passing for at least one year from the last menstruation or having a hormonal test with FSH of more than 40 international units The presence of vaginal atrophy Sexual performance score less than or equal to 26/5 Have sex and monogamy
Exclusion criteria
Exclusion criteria: vaginal infection Treatment with HRT or taking sex hormones during 8 weeks before study Any major disease genital Consuming Smoking, alcohol or any opiate Uterine bleeding and spotting Body mass index more than 30 Breast disease with unknown cause Use of vaginal drugs or any lubricant for at least 15 days before the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms of vaginal atrophy. Timepoint: At the beginning of the intervention and 14 and 56 days after the start of the intervention. Method of measurement: The combined questionnaire vaginal atrophy symptoms.;The percentage of the maturity of the cells of the vagina. Timepoint: before and after intervention. Method of measurement: Vaginal smears.;The acidity of the vagina. Timepoint: before and after intervention. Method of measurement: PH strip. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: before and after intervention. Method of measurement: Female sexual function index questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactIlnaz Zohrabi
Ahvaz University of Medical Sciences
Outcome results
None listed